[1]
2025. A Review on the Potential of Biased Agonism in the GPCR Signalosome for Therapeutic Efficacy: Review Article. Journal of Pharma Insights and Research. 3, 5 (Oct. 2025), 355–367. DOI:https://doi.org/10.69613/vn401w15.